4 01, 2023

Rational Harm- Benefit Assessments By Age Group Are Required For Continued Covid- 19 Vaccination

January 4, 2023|Fatality, illness, Inquiry, International, Pharma, Research, Vax Damage|

The authors estimate that at least 18.5 serious adverse events could occur for every COVID- 19 hospitalization prevented.

From January 2021 to the time of writing, 1598 athletes suffered cardiac arrest, 1101 of which with deadly outcome.8 Notably, in a 38-years timespan (1966-2004), 1101 athletes under the age of […]

2 01, 2023

A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19

January 2, 2023|Fatality, International, Pharma, Research, Vax Damage|

Abstract

The current report presents the case of a 76-year-old man with Parkinson’s disease (PD) who died three weeks after receiving his third COVID-19 vaccination. The patient was first vaccinated in May 2021 with the ChAdOx1 nCov-19 vector vaccine, followed by two doses of the BNT162b2 mRNA vaccine […]